Home / Inspections / 1121634

FDA Inspection 1121634 — Shilpa Medicare Limited

Shilpa Medicare Limited — FEI 3009876430

The FDA completed an inspection of Shilpa Medicare Limited on February 25, 2020 in Jadcherla, Mahabubnagar District. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 25, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jadcherla, Mahabubnagar District (India)

Facility

Other inspections at this facility

  • 1101543 (VAI Fri Sep 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1036712 (VAI Thu Nov 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1020609 (NAI Fri Jul 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983085 (NAI Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 939599 (VAI Wed Aug 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources